Evidence map›Paper›PMID 29024851›Full record

ArticleVirology2017

Infectivity of Sf-rhabdovirus variants in insect and mammalian cell lines.

Ajay B Maghodia, Donald L Jarvis

Open access · greenAbstract read
In one paragraph

Article in Virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ajay B MaghodiaGlycoBac, LLC, Laramie, WY 82072, USA.
Donald L JarvisGlycoBac, LLC, Laramie, WY 82072, USA; Department of Molecular Biology, University of Wyoming, Laramie, WY 82071, USA. Electronic address: dljarvis@uwyo.edu.
University of Wyoming · US

Funding

Glycoengineered insect cells for commercial biologics manufacturingR44GM102982 · NIGMS · GLYCOBAC, LLC · PI BLAIR, CAROL D, JARVIS, DONALD L. · 2016 to 2017
$940k
Glycoengineering insect cells for commercial recombinant glycoprotein productionR43GM102982 · NIGMS · GLYCOBAC, LLC · PI GEISLER, CHRISTOPH, JARVIS, DONALD L. · 2013 to 2014
$599k
Glycoengineered baculoviruses for the production of more efficacious influenza vaR43AI112118 · NIAID · GLYCOBAC, LLC · PI MAGHODIA, AJAYKUMAR B. · 2014 to 2014
$225k
NIAID NIH HHS R43 AI112118NIGMS NIH HHS R43 GM102982NIGMS NIH HHS R44 GM102982
6 · The paper itself

Abstract

Sf-rhabdovirus was only recently identified as an adventitious agent of Spodoptera frugiperda (Sf) cell lines used as hosts for baculovirus vectors. As such, we still know little about its genetic variation, infectivity, and the potential impact of variation on the Sf-rhabdovirus-host interaction. Here, we characterized Sf-rhabdoviruses from two widely used Sf cell lines to confirm and extend information on Sf-rhabdovirus variation. We then used our novel Sf-rhabdovirus-negative (Sf-RVN) Sf cell line to assess the infectivity of variants with and without a 320bp X/L deletion and found both established productive persistent infections in Sf-RVN cells. We also assessed their infectivity using heterologous insect and mammalian cell lines and found neither established productive persistent infections in these cells. These results are the first to directly demonstrate Sf-rhabdoviruses are infectious for Sf cells, irrespective of the X/L deletion. They also confirm and extend previous results indicating Sf-rhabdoviruses have a narrow host range.

Indexed as

InsectaMammalsAnimalsCattleCell LineGene Expression Regulation, ViralHeLa CellsHost SpecificityHumansKidneyRhabdoviridaeViral ProteinsViral ProteinsAdventitious virusesBaculovirus expression systemInsect cellsSf-rhabdovirus

Identifiers

PMID29024851
PMCPMC5651996
OpenAlexW2763185647

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.